Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2021 Oct;49(5):1055-1060.
doi: 10.1007/s15010-020-01561-x. Epub 2020 Dec 17.

A challenging complication following SARS-CoV-2 infection: a case of pulmonary mucormycosis

Affiliations
Case Reports

A challenging complication following SARS-CoV-2 infection: a case of pulmonary mucormycosis

Daniela Pasero et al. Infection. 2021 Oct.

Abstract

Severe acute respiratory syndrome coronavirus 2 infection might induce a significant and sustained lymphopenia, increasing the risk of developing opportunistic infections. Mucormycosis is a rare but severe invasive fungal infection, mainly described in immunocompromised patients. The first case of a patient diagnosed with coronavirus disease (COVID-19) who developed a pulmonary mucormycosis with extensive cavitary lesions is here reported. This case highlights how this new coronavirus might impair the immune response, exposing patients to higher risk of developing opportunistic infections and leading to worse outcomes.

Keywords: Mucormycosis; Opportunistic infections; SARS-Cov-2.

PubMed Disclaimer

Conflict of interest statement

All authors declare that they have no conflicts of interest.

Figures

Fig. 1
Fig. 1
Microbiological sample from bronchial aspirate: morphology of Rizhopus spp.. Lactophenol cotton blue preparation showed aseptate broad hyphae, sporangia and sporangiospores
Fig. 2
Fig. 2
a Thoracic computed tomography (CT) scan showed buried cavitary lesions in the left lung; b cranial CT scan showed corpuscular material in the left maxillary sinus

Comment in

References

    1. Bassetti M, Bouza E. Invasive mould infections in the ICU setting: complexities and solutions. J Antimicrob Chemother. 2017;72:i39–i47. doi: 10.1093/jac/dkx032. - DOI - PubMed
    1. Lin E, Moua T, Limper AH. Pulmonary mucormycosis: clinical features and outcomes. Infection. 2017;45:443–448. doi: 10.1007/s15010-017-0991-6. - DOI - PubMed
    1. Peng M, Meng H, Sun Y, et al. Clinical features of pulmonary mucormycosis in patients with different immune status. J Thorac Dis. 2019;11:5042–5052. doi: 10.21037/jtd.2019.12.53. - DOI - PMC - PubMed
    1. Liu J, Li S, Liu J, et al. Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV-2 infected patients. EBioMedicine. 2020;55:102763. doi: 10.1016/j.ebiom.2020.102763. - DOI - PMC - PubMed
    1. Zhu N, Zhang D, Wang W, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020;382:727–733. doi: 10.1056/NEJMoa2001017. - DOI - PMC - PubMed

Publication types